Mazzaro, C.; Bomben, R.; Gragnani, L.; Visentini, M.; Agostinis, P.; Marri, S.; Zignego, A.L.; Gattei, V.
The Role of Direct-Acting Antivirals (DAAs) in Hepatitis C Virus-Associated Lymphoproliferative Disorders. Cancers 2026, 18, 2501.
https://doi.org/10.3390/cancers18152501
AMA Style
Mazzaro C, Bomben R, Gragnani L, Visentini M, Agostinis P, Marri S, Zignego AL, Gattei V.
The Role of Direct-Acting Antivirals (DAAs) in Hepatitis C Virus-Associated Lymphoproliferative Disorders. Cancers. 2026; 18(15):2501.
https://doi.org/10.3390/cancers18152501
Chicago/Turabian Style
Mazzaro, Cesare, Riccardo Bomben, Laura Gragnani, Marcella Visentini, Paolo Agostinis, Silvia Marri, Anna Linda Zignego, and Valter Gattei.
2026. "The Role of Direct-Acting Antivirals (DAAs) in Hepatitis C Virus-Associated Lymphoproliferative Disorders" Cancers 18, no. 15: 2501.
https://doi.org/10.3390/cancers18152501
APA Style
Mazzaro, C., Bomben, R., Gragnani, L., Visentini, M., Agostinis, P., Marri, S., Zignego, A. L., & Gattei, V.
(2026). The Role of Direct-Acting Antivirals (DAAs) in Hepatitis C Virus-Associated Lymphoproliferative Disorders. Cancers, 18(15), 2501.
https://doi.org/10.3390/cancers18152501